The SLC40A1 gene gives your body instructions for ferroportin, a protein that moves iron out of cells and helps keep iron levels balanced. If this gene does not work properly, iron can build up in tissues or become trapped in certain cells, which may affect the liver, spleen, joints, and blood test results. Pathogenic variants in the SLC40A1 gene can cause ferroportin disease, an inherited condition linked to iron overload. This gene is mainly discussed in medical settings rather than popular culture.
What is a gene?
Genes are sections of DNA that hold instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for building proteins, which do much of the cell’s work. Others mainly guide when certain activities happen, where they take place, and how active they are. As a group, genes affect how the body grows and works, and they can also influence how you react to food, stress, or medicines. You can read more about this topic in the LearnHub.
Overview
SLC40A1Gene function
What if the gene works
The SLC40A1 gene makes ferroportin, a protein that moves iron out of cells and into the blood.
This helps your body balance iron for red blood cells and other tissues.
Risk
What if the gene does not work
Variants in the SLC40A1 gene can cause ferroportin disease, a form of inherited iron overload from reduced iron release out of cells. Milder and more severe variants can change when iron builds up and whether liver problems appear.
Treatment
What does that mean for your treatment
For pathogenic variants in the SLC40A1 gene, treatment is usually tailored to the pattern of iron overload. With loss-of-function variants, iron removal by phlebotomy may still be used, but it is often started cautiously and adjusted more gently because anemia can develop even while stored iron remains high. No SLC40A1-specific drug treatment is currently established in guidelines.
Conditions associated with SLC40A1
Gene function
What if the gene works
Your body needs a steady supply of iron to make red blood cells and support energy use. The SLC40A1 gene helps manage that flow by making ferroportin, a protein that moves iron out of cells. This helps explain how the SLC40A1 gene helps control iron levels throughout the body.
The SLC40A1 gene makes ferroportin, a protein that moves iron out of certain cells and into the blood. This keeps iron circulating so it can reach tissues that need it.
In the small intestine, ferroportin passes absorbed iron from gut lining cells into the bloodstream. This is how iron from food becomes available for everyday body functions.
Cells that clear away old red blood cells use ferroportin to return recovered iron to the blood. Your body can then reuse that iron to support new red blood cell production.
Liver cells use ferroportin to release some stored iron when your body needs it. This helps keep iron supplies steady between meals and over time.
What is a variant?
A genetic variant is a small alteration in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC40A1 gene can change the ferroportin protein so it is less stable, reaches the cell surface poorly, or does not respond normally to hepcidin, the signal that controls iron release. Some SLC40A1 gene variants mainly reduce iron export, while others make ferroportin resist this control signal and stay active longer. This spectrum helps explain why ferroportin disease can range from milder findings to earlier or more marked iron overload.
How variants are linked to conditions
Pathogenic variants in the SLC40A1 gene cause ferroportin disease, also called hemochromatosis type 4, and the SLC40A1 gene and iron overload link is well established. People with this inherited condition may have high ferritin, iron buildup in the liver, tiredness, joint symptoms, or later liver damage, although the pattern and severity can vary. Some SLC40A1 gene variants are linked to a more typical hereditary hemochromatosis picture with higher transferrin saturation.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are widely found in the general population. Most do not have a direct impact on health and instead reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when more than one gene and environmental factors contribute. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For people with an SLC40A1 change, the main risk comes from the inherited variant itself, but iron buildup can vary from person to person. It may be greater in men, after menopause, and with heavy alcohol use, liver disease, or extra iron from supplements; there is not enough evidence to say lifestyle changes alone prevent the condition.
Inheritance of SLC40A1 variants
SLC40A1-related conditions are usually inherited in an autosomal dominant pattern, which means a person only needs one disease-causing variant in the SLC40A1 gene to be affected. If a parent carries such a variant, each child has a 50% chance of inheriting it. This is the main answer to how SLC40A1 variants are inherited in families. Men and women can inherit and pass on the variant equally.
What does my SLC40A1 result mean for my family?
For many living with a disease-causing change in the SLC40A1 gene, close relatives can also carry the same change because this condition usually runs in families in a dominant pattern. That means parents, brothers, sisters, and children may also have a chance of having it, even if their symptoms are mild or they feel well. Family members may want to talk with their doctor about whether iron testing or genetic testing makes sense for them.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry variants in the SLC40A1 gene, clinicians use genetic testing on a blood or saliva sample. SLC40A1 genetic testing reads the gene's DNA code and checks for changes that may help explain iron overload or a family history. Results may show a disease-causing variant, a harmless change, or a change whose meaning is still unclear.
When should I consider getting a genetic test?
Consider testing for changes in the SLC40A1 gene if blood tests show ongoing high ferritin or other signs of iron overload, especially when common causes have been ruled out. It can also help if iron buildup or hemochromatosis runs in your family.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals varies by the condition and the type of variant involved. Over time, how the body works is shaped by many other factors too, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles medicines, so the same treatment may work differently from one person to another. Some people process a drug more slowly or more quickly, which can change how much of the medicine reaches the body and how strongly it acts. This can influence how well a treatment works or how likely someone is to notice side effects, alongside age, liver and kidney function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. By studying the links between genes and drugs, it helps explain why the same treatment can work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body handles it. Understanding this can support treatment decisions that are more informed and more individualized. More on this topic is available in the LearnHub.
Drugs influenced by the SLC40A1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choice or dose, so general concerns about your health, iron levels, or medicines are best discussed with your doctor. Some research has looked at SLC40A1 and how the body handles iron-related treatment, but this is not used routinely in everyday care.
History
SLC40A1 entered the medical literature when doctors studying families with inherited iron overload realized that not all cases fit the better known HFE form of hemochromatosis. In recent decades, awareness of this gene’s role has grown as researchers linked SLC40A1 variants to a distinct condition now called ferroportin disease, also known as hemochromatosis type 4. Around the early 2000s, this discovery helped explain why some families showed a different pattern of iron test results and organ involvement than expected. From these first observations, research expanded steadily, and genetic testing began to separate SLC40A1 related iron overload from other inherited iron conditions. Scientific classifications changed as researchers learned more about the gene. That shift gave families a clearer label for a condition that had often been grouped too broadly in the past.